Ashland

Abstract Background/Objectives: The development of extended-release oral dosage forms remains a complicated and time consuming process, particularly during early formulation...

This year, the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology takes place in Prague, Czech Republic.   From...

Abstract Poor tablet hardness and drug re-crystallization are two common challenges of amorphous solid dispersion (ASD) formulations prepared with hot-melt...

This year DCAT Week opens its doors in New York City. From 23th to 26th March the DCAT Week 2026...

Abstract Background: Buccal administration offers direct access to systemic circulation, improving drug bioavailability when compared with the conventional oral route....

Abstract Effective dry-state stabilization of bacteriophages is crucial for expanding their therapeutic use. This study builds on previous findings that...

Abstract Poor solubility of curcumin (Cur) has greatly limited its applications. To establish Cur amorphous solid dispersions (Cur ASDs) with...

Abstract Purposes The tabletability flip phenomenon (TFP), where an active pharmaceutical ingredient (API) with poorer tabletability exhibits better tabletability when...

Abstract Polymeric micelles are promising nanocarriers for improving the solubility and therapeutic efficacy of poorly water-soluble drugs. In this study,...

Abstract Background/Objectives: Rutin, a bioactive flavonol glycoside known for its antioxidant, anti-inflammatory, and anticancer activities, faces limited clinical application due...